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Insulin and insulin-like growth factor 1 (IGF-1) may play a role
in the regulation of sodium balance by increasing basal and
aldosterone-stimulated transepithelial sodium transport in
the aldosterone-sensitive distal nephron (ASDN). As insulin
and IGF-1 are capable of binding to each other’s receptor
with a 50- to 100-fold lower affinity than to their cognate
receptor, it is not clear which receptor mediates its respective
sodium transport response in the ASDN. The aim of the
present study was to characterize the IGF-1 regulation of
Naþ transport in the mCCDcl1 cell line, a highly differentiated
cell line which responds to physiological concentrations
(K1/2¼ 0.3 nM) of aldosterone. IGF-1 increased basal
transepithelial Naþ transport with a K1/2 of 0.4170.07 nM.
Insulin dose-response curve was displaced to the right
50-fold, as compared to that of IGF-1 (K1/2¼ 20.073.0 nM),
indicating that it acts through the IGF type 1 receptor
(IGF-1R). Co-stimulation with IGF-1 (0.3 nM) (or 30 nM insulin) and
aldosterone (0.3 nM), either simultaneously or by pretreating
the cells for 5 h with aldosterone, induced an additive
response. The phosphatidylinositol-30 kinase (PI3-K) inhibitor
LY294002 completely blocked IGF-1 and aldosterone induced
and co-induced currents. As assessed by Western blotting,
protein levels of the serum-, and glucocorticoid-induced
kinase (Sgk1) were directly and proportionally related to the
current induced by either or both IGF-1 and aldosterone,
effects also blocked by the PI3-K inhibitor LY294002. IGF-1
could play an important physiological role in regulating basal
sodium transport via the PI3-K/Sgk1 pathway in ASDN.
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The role of aldosterone in regulating sodium reabsorption in
the aldosterone-sensitive distal nephron (ASDN) is well
defined.1 Insulin and insulin-like growth factor 1 (IGF-1) are
also known to stimulate transepithelial sodium (Naþ )
transport in different models of the distal nephron, but
while insulin role on Naþ reabsorption has been extensively
studied in different in vitro, ex vivo and in vivo models (see
reviews2–5), the precise role of IGF-1 is less understood, and
only a small number of studies concerning IGF-1 effect on
Naþ reabsorption have been published.6–12 In many
instances, the effect of insulin on Naþ transport has been
measured by applying supra-physiological concentrations.
Noteworthy, insulin and IGF-1 are capable of binding to each
other’s receptors with a 50- to 100-fold lower affinity than
that of their own cognate receptor.13 Further difficulties
regarding the specific roles of insulin versus those of IGF-1
have arisen from the demonstration that many of the cellular
substrates mediating the effects of these receptors are the
same: insulin receptor substrates (IRS1 to 4) and Src–homo-
logy–collagen (Shc) are, among others, main substrates for
both receptors. Moreover, the activation of phosphatidylino-
sitol-30 kinase (PI3-K) and mitogen-activated protein kinase
pathways, respectively, has been implicated in both cases.14
The serum- and glucocorticoid-induced kinase 1 (Sgk1), a
key enzyme on sodium reabsorption regulation by aldoste-
rone and insulin,12,15,16 has been shown to be phosphorylated
and activated by the PI3-K pathway induced by IGF-1.17,18
Altogether these findings suggest that IGF-1 could play a role
in regulating ion transport in the kidney via activation of the
PI3-K/Sgk1 pathway.
Remarkably, despite the pulsability aspect of growth
hormone secretion, free plasma IGF-1 is not fluctuating
during the circadian cycle,19 whereas plasma aldosterone is
varying according to circadian variation of blood volume and
plasma insulin peaks at high values after feeding (Table 1).
We hypothesize that IGF-1 could control baseline sodium
transport in ASDN over long periods of time, whereas
aldosterone and insulin would control sodium transport
acutely, rapidly, and reversibly, that is for a couple of hours,
according to their respective physiological stimuli.
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To characterize the role of IGF-1 in Naþ transport in the
distal tubule, we used the mCCDcl1 cells,
20 a highly
differentiated cell line, which displays unique differentiation
properties. mCCDcl1 cells are highly responsive to aldoster-
one.20 Our aims were to determine:
(i) the long vs short term effects of the hormones on
sodium transport and to determine their respective
sensitivity to Actinomycin D to define their genomic
vs non-genomic effects;
(ii) the relative potency of insulin vs that of the IGF-1 in
the regulation of the Naþ transport response by
measuring their dose–response curves in order to
determine their physiological relevance;
(iii) the interaction between aldosterone and insulin/IGF-1
on the Naþ transport responses; and
(iv) the implication of the PI-3-K/Sgk1 pathway by
inhibiting the PI-3 K with LY294002 and by measuring
the resulting currents, as well as the level of the total
pool (and its phosphorylated forms) of Sgk-1 by
Western blotting, in order to correlate the electro-
physiological and biochemical responses.
RESULTS
Time course of insulin and IGF-1 effects on Isc: early vs late
effects
Both insulin and IGF-1 may mediate their effects by short
term (within 5–10 min), non-genomic and long-term (41 h)
genomic actions. The time course of effect of insulin and
IGF-1 on the short-circuit current is shown in Figure 1. Two
hours before hormonal addition, the apical and basolateral
media were changed for fresh culture medium. At t2 h,
baseline PD was 20.871.9 mV (s.d.), n¼ 12; baseline short
circuit current (SCC) was 5.770.5 mA/cm2 (s.d.) and
transepithelial resistance 37617536 Ohm.cm2 (s.d.). Theses
basal values were similar to that reported previously.20 After
medium changes (t2 h), SCC increased progressively to reach
a maximum 3 h later. Upon addition (to) of insulin or IGF-1
(closed and open symbols, respectively), Isc rapidly rose over
controls to reach a maximum at 1 h and then decreased
slowly, remaining at higher levels than controls. After 10 min
of hormonal exposure, Isc reached already 50% of the
maximal response. The time course of responses to IGF-1 and
insulin were undistinguishable. Some of the effects described
in different tissues after IGF type 1 receptor (IGF-1R)
activation are mediated by transcription regulation.21 To
analyze the putative role of transcription on the induction of
sodium transport by insulin and IGF-1 in our cell line, we
treated the cells with 1 mM Actinomycin D (ActD) at the same
time as insulin or IGF-1 (1 mM or 10 nM, respectively). We
concluded that a significant portion of the hormonal
response (41 h) was mediated by genomic actions (see
Supplementary Information 1).
Dose dependency of insulin and IGF-1 effects on Isc: relative
potency of each agonist
At present, the only way to distinguish whether the observed
effects were mediated through the IGF-1 or insulin receptors
is to perform detailed dose–response curves under the same
experimental conditions. As shown in Figure 2, at maximal
concentrations, similar maximal responses were obtained
after 1 h of treatment with either 1mM insulin (panel a,
10.470.3mAmp/cm2) or 30 nM IGF-1 (panel b, 9.87
0.3mAmp/cm2). The induced current was fully blocked
Table 1 | Plasma concentrations, receptor Kd and half
maximum activation K1/2 of transepithelial sodium transport
for insulin, IGF-1, and aldosterone
Hormone
Plasma
concentration
(nM)
Receptor
Kd (nM)
Sodium
response
K1/2 (nM)
IGF-1 (free plasma conc)
Mouse 0.4–0.8a 1.0b 0.4b
Human 0.9–1.2c
Obese 1.8–2.4c
Acromegaly 4.5–6.0c
Insulin
Mouse 0.08–0.170d 0.5b 20b
Human
Fasting 0.03e
Feeding 0.4e
Obese (fasting) 0.08e
Aldosterone
Mouse 0.6 (MR)e 0.5e
85 (GR)e 90e
am 0.6
pm 1.2
Salt restriction 6
Salt load 0.1
aFree plasma concentration assuming 1–2% of total binding.
bPresent data.
cFree plasma concentration, Frystyk.19
dHuang et al.29
eGaeggeler et al.20
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Figure 1 | Time course of insulin and IGF-1-induced changes in
transepithelial Naþ currents. Cells were treated at t0 with: vehicle
(x, X), IGF-1 (0.6 nM, open circle) or insulin (60 nM, closed circle). The
delta of the induced current as respect to t¼ 0 (Isc stimulatedIsc at
t¼ 0) is represented.
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by 10 mM amiloride (data not shown), implying that for both
hormones the response is mediated by the epithelial sodium
channel. After 1 h of stimulation, a slow and continuous
decrease of Isc was comparable for both hormones. After 6 h
of treatment with the highest hormonal concentrations, the
short-circuit current was still statistically different from
the control baseline (insulin: 6.670.2 (s.e.m.) mAmp/cm2
and control: 3.970.2 mAmp/cm2; IGF-1: 6.670.2 mAmp/cm2
and control: 3.970.2 mAmp/cm2; Po0.001). However, the
dose–response curve shows a striking 50-fold difference in
the sensitivity to each hormone, being markedly displaced
to the right for insulin (panel c, K1/2-ins¼ 20.073.0 nM vs
K1/2-IGF-1¼ 0.4170.7 nM; (Ins)threshold¼ 3 nM vs (IGF-1)threshold
¼ 0.1 nM; (Ins)max¼ 1mM vs (IGF-1)max¼ 10 nM), indicating
that both hormones act via the IGF-1R. These effects are
mediated by receptors located at the basolateral membrane (see
Supplementary Information 2).
We were surprised to observe that the K1/2 for insulin was
30- to 50-fold higher than those previously reported on other
epithelial cell lines.22 As insulin concentration in our culture
conditions is high and was maintained (at B900 nM) until
15 h before the initiation of the experimental protocols, it
could affect a subsequent response to lower concentrations of
insulin. To rule out this possibility, we performed additional
dose-response to insulin by comparing responses of cells
deprived of insulin for 5 days and cells exposed to insulin
until 15 h before the experiments (standard protocol). The
K1/2 did not change significantly (49 nM vs 27 nM, respec-
tively) well within the variability of the measurement. Under
the same experimental conditions the K1/2 for IGF-1
remained low (0.3 nM), as reported above.
Co-stimulation with aldosterone and IGF-1 (or insulin)
induces an additive effect on the Isc
To analyze the effect of physiological concentrations of either
aldosterone or IGF-1 on sodium transport by binding to their
respective receptors (mineralocorticoid receptor and IGF-
1R), we first treated the cells with concentrations close to the
K1/2 of either IGF-1 (or insulin) or aldosterone alone or both
hormones (0.3 nM IGF-1 and 0.3 nM aldosterone). Aldoster-
one induction of Isc at this low concentration peaks after 2 h
of treatment. Also, as shown above, IGF-1 induction of Isc
peaks at 1 h and decreases subsequently (Figure 3a).
Interestingly, IGF-1 response was more than 50% higher
than that of aldosterone (at t¼ 2 h, DIscCtrl¼ 2.370.2 mA/
cm2; DIscIGF-1¼ 6.070.9 mA/cm2; DIscAldo¼ 9.571.3 mA/
cm2). Moreover, an additive effect can be observed (dotted
line), starting after 2 h of treatment (Po0.1) and after 3 h
(Po0.05) (Figure 3a). When substituting 0.3 nM IGF-1 by
30 nM insulin, inducing an equivalent response, similar
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Figure 2 | Dose–response of insulin and IGF-1-induced changes in transepithelial Naþ currents. Dose–response for (a) insulin or (b) IGF-1.
The delta of the induced current as respect to t¼ 0 (Isc stimulatedIsc at t¼ 0) is represented for vehicle (closed down-pointing triangle),
insulin (closed up-pointing triangle), and IGF-1-(closed square) treated cells (n¼ 6). Increasing concentrations of hormone are represented by
increasing size of the symbol (insulin: 0.3 nM, 1 nM, 10 nM, 30 nM, 100 nM, and 1000 nM; IGF-1: 10 pM, 0.1 nM, 0.3 nM, 1 nM, 10 nM, 30 nM). At t¼2 h,
cells were fed with DMEM:F12 (1:1), and at t¼ 0 h insulin, IGF-1, or the vehicle, were added on the basolateral side. At the end of the
experiment, 10mM amiloride was added to the apical side, that blocked 99% of the induced current (not shown). (c) Dose–response comparison
for insulin (closed up-pointing triangle) and IGF-1 (closed square) at t¼ 1 h (time point of maximal stimulation, see Figure 1). The delta
stimulated current (Isc stimulatedIsc control) of the induced current at t¼ 1 h is represented. The dotted line represents the dose–response
curve as calculated, using the nonlinear fit routine of the Kaleidagraphs program.
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results were obtained (Figure 3b). The additive effect (dotted
line) is statistically different from t1 h on (Po0.001).
To analyze the putative role of IGF-1 in Naþ reabsorption
in conditions of mineralocorticoid excess (which should
occupy both mineralocorticoid receptor and GR20), we then
studied the response after co-stimulating the cells with 300 nM
aldosterone and 0.3 nM IGF-1 (Figure 4a) or the concentra-
tion of insulin inducing an equivalent response (30 nM,
Figure 4b). Aldosterone induction of Isc at this elevated concentra-
tion is already very high after only 1 h of treatment
(DIscAldo¼ 20.672.1 mA/cm2 in the IGF-1 experiment and
DIscAldo¼ 23.170.7 mA/cm2 in the insulin experiment). At
this time point, we could observe a statistically significant
additive effect after co-stimulation with 30 nM insulin
(DIscAldoþ Ins¼ 31.470.8 mA/cm2; Po0.001), but not with
0.3 nM IGF-1 (DIscAldoþ IGF-1¼ 24.773.5 mA/cm2; P¼ 0.32).
By its transcriptional effect, aldosterone could change the
IGF-1 responsiveness. To investigate this possibility, we
pretreated the cells with 0.3 nM aldosterone for 5 h and then
performed a dose–response curve for IGF-1 at t¼ 1 h,
corresponding to the maximal measured response. The
dose–response curve (Figure 5) shows that, although starting
from a higher baseline current owing to the aldosterone
stimulation, IGF-1 can produce a similar increment of Isc as
in cells that had not been pretreated with aldosterone. Similar
results were obtained with an equivalent insulin treatment
(30 nM) after the 5 h aldosterone pretreatment (data not
shown). In summary, co-stimulation with IGF-1 and
physiological concentrations of aldosterone (0.3 nM) in
different conditions (simultaneously or after a 5 h pretreat-
ment with aldosterone) gives a long lasting additive response.
PI3-K inhibitor LY294002 blocks IGF-1-induced
transepithelial current in the presence or absence of
aldosterone
The PI3-K pathway can be activated by IGF-1R stimulation,
in its turn phosphorylating and activating Sgk1.17,18 Sgk1 will
mediate the sodium transport response by phosphorylating
Nedd4-2, which interacts directly with the cytoplasmic
domains of epithelial sodium channel.12,16 The PI3-K path-
way has also been shown to be necessary for aldosterone
induction of Naþ current via Sgk1.23,24 We hypothesized
that, in our model, IGF-1 could induce Naþ transport by
phosphorylating and activating Sgk1 via PI3-K. To test this
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Figure 4 | Co-stimulation with 300 nM aldosterone and 0.3 nM IGF-1 or 30 nM insulin induces an additive effect on sodium transport only
at t¼ 1 h. Time course curves for co-stimulation with 300 nM aldosterone and 0.3 nM IGF-1 (a, n¼ 9) or 30 nM insulin (b, n¼ 9). Cells were
treated with: vehicle (closed down-pointing triangle), IGF-1 or insulin (closed square or closed up-pointing triangle, respectively), 300 nM
aldosterone (closed circle), or both aldosterone and IGF-1 or insulin (closed diamond). The delta of the induced current as respect to t¼ 0
(Isc stimulatedIsc at t¼ 0) is represented. The dotted line corresponds to the calculated additive effect of co-stimulation (control
condition delta currentþ IGF-1 or insulin inductionþ aldosterone induction).
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Figure 3 | Co-stimulation with 0.3 nM aldosterone and 0.3 nM IGF-1 or 30 nM insulin induces an additive effect on sodium transport.
Time course curves for co-stimulation with 0.3 nM aldosterone and 0.3 nM IGF-1 (a, n¼ 9) or 30 nM insulin (b, n¼ 12). Cells were treated
with: vehicle (closed down-pointing triangle), IGF-1 or insulin (closed square or closed up-pointing triangle, respectively), 0.3 nM
aldosterone (closed circle), or both aldosterone and IGF-1 or insulin (closed diamond). The delta of the induced current as respect to t¼ 0
(Isc stimulatedIsc at t¼ 0) is represented. The dotted line corresponds to the calculated additive effect of co-stimulation (control condition
delta currentþ IGF-1 or insulin inductionþ aldosterone induction).
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hypothesis, we added the PI3-K inhibitor LY294002 at the
same time as either or both IGF-1 and aldosterone. 50 mM
LY294002 did not affect the baseline current up to 3 h after
the treatment. As expected, LY294002 completely blocked
the stimulation of sodium transport by either low (0.3 nM,
Figure 6a) or high (300 nM, Figure 6b) aldosterone concen-
trations. In addition, induction of Isc by 0.3 nM IGF-1 was
completely abolished by LY294002, as well as the current
induced by the co-stimulation with 0.3 nM aldosterone
(Figure 6a). In the case of co-stimulation with 0.3 nM IGF-1
and 300 nM aldosterone, LY294002 could block the induced
response at t¼ 1 h, but from time 2 h on, PI3-K inhibitor was
not able to maintain the current at the baseline level
(compare aldosteroneþ IGF-1þ LY-treated cells with IGF-1
alone treated cells) (Figure 6b).
IGF-1 induces Sgk1 phosphorylation via the PI3-K
To confirm the participation of Sgk1 in the induction of
Naþ current by IGF-1, we analyzed Sgk1 expression by
immunoblot in different conditions (Figures 7–10). Figure 7
shows the characterization of the anti-Sgk antibody and Sgk1
expression and phosphorylation. A band that matches up the
predicted molecular weight of the non-phosphorylated Sgk1
(49 kDa) is observed (arrow head). Three more slowly
migrating bands can be clearly seen (bracket) as well as a
nonspecific band (star). To check whether they correspond to
different phosphorylation states of Sgk1 (up to four different
phosphorylation sites have been experimentally described),
we have treated with l-phosphatase protein extracts from
cells stimulated with 300 nM aldosterone in the absence or
presence of the PI3-K inhibitor LY294002 for 2 h (panel a,
lanes 3 and 4), or with 0.3 nM IGF-1 for 1 h (two different
samples, panel b, lanes 6 and 8). Aldosterone at this high
concentration is known to strongly induce Sgk1 expression
and phosphorylation, as can be seen when comparing the
expression levels of Sgk1 (panel a, 25 mg protein, lanes 1 and
2) with its expression levels in presence of 0.3 nM IGF-1
(panel b, 50 mg protein, lanes 5 and 7). In mCCDcl1 cells
treated with 300 nM aldosterone (panel a, lane 1), after the
l-phosphatase treatment (lane 2), the first band from the top
disappears, and the second one is getting weaker, suggesting
that both are phosphorylation states of Sgk1, on one hand,
and that l-phosphatase cannot completely hydrolyze all
phosphates present, on the other hand. When cells have been
treated simultaneously with aldosterone and the PI3-K
inhibitor LY29400 (panel a, 50 mg protein, lane 3), Sgk1
expression is lower, suggesting that PI3-K would not only
phosphorylate but control Sgk1 protein expression, as
reported previously.15,23 Moreover, the top band absent
after l-phosphatase treatment (lane 2) is also absent after LY
treatment with (lane 4) or without phosphatase treatment
(lane 3), consistent with PI3-K-dependent phosphorylation
of Sgk1. Finally, treatment of this protein extract with
l-phosphatase (lane 4) induces a decrease in the remaining
highest molecular weight band, suggesting the presence of
Sgk1 phosphorylations independent of the PI3-K pathway, as
shown previously.25,26 In all cases, the decrease in the
intensity of the slower migrating bands is accompanied by
a concomitant increase in the two bands with a lower
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Figure 5 | IGF-1 induces an increase in Isc on cells pretreated for
5 h with 0.3 nM aldosterone. Dose–response curves for 1 h
stimulation with IGF-1 in cells pretreated (closed diamond) or not
(closed square) with 0.3 nM aldosterone for 5 h (n¼ 6). The absolute
transepithelial current (Isc) value at t¼ 1 h of the IGF-1 stimulation is
represented.
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Figure 6 | The PI3-K inhibitor LY294002 blocks the aldosterone and IGF-1 stimulated and co-stimulated current. Time course curves
for co-stimulation with 0.3 nM IGF-1, 50mM LY294002 and 0.3 nM (a, n¼ 6) or 300 nM (b, n¼ 6) aldosterone. Cells were treated with vehicle
(down-pointing triangle), IGF-1 (square), aldosterone (circle), or both aldosterone and IGF-1 (closed diamond) in the absence (closed
symbols) or presence (open symbols) of LY294002. The delta of the induced current as respect to t¼ 0 (Isc stimulatedIsc at t¼ 0)
are shown.
120 Kidney International (2007) 71, 116–125
o r i g i n a l a r t i c l e E Gonzalez-Rodriguez et al.: IGF-1 and sodium transport
molecular weight (including the non-phosphorylated Sgk1).
Supporting the idea that l-phosphatase can only partially de-
phosphorylate Sgk1, the analysis of protein extracts from cells
stimulated with 0.3 nM IGF-1 for 1 h (panel b, two different
samples, lanes 5 and 7) shows that only the slowest migrating
band disappears, with a concomitant increase in the intensity
of two lower molecular weight bands (lanes 6 and 8).
The early (10 min) non-genomic effects of IGF-1 are
presumably linked to the direct activation of a small basal
protein pool of Sgk-1 by the PI3-K pathway. Figure 8 shows
the effect of 1 h stimulation with IGF-1 added either on the
apical membrane (10 nM) (lane 2) or on the basolateral
membrane (0.1 nM and 10 nM) (lanes 3 and 4, respectively).
No changes of Sgk-1 phosphorylation (panel a), protein pool
(panel b) or sodium transport (panel c) were observed when
adding IGF-1 to the apical membrane (lane 2). When applied
on the basolateral side (lanes 3 and 4), IGF-1 induced a dose-
dependent increase of Sgk1 phosphorylation (panel a),
protein pool (panel b), and sodium transport (panel c).
IGF-1 treatment induced mainly an increase in Sgk1
phosphorylation levels and a small effect on the non-
phosphorylated. These results indicate that Sgk1 is one of
the mediators of IGF-1R-mediated response on Naþ
transport and that IGF-1 not only alters the phosphorylation
pattern of Sgk-1, but is also able to increase its protein pool.
We then analyzed Sgk1 expression and phosphorylation
induced by 1 h treatment with IGF-1 after a 5 h incubation
with 0.3 nM aldosterone (Figure 9). The 6-h treatment with
0.3 nM aldosterone increased Sgk-1 phosphorylation (panel a,
lanes 4–6), and protein pool (panel c, lanes 4–6). Sodium
transport was increased by 0.3 nM aldosterone only in the
presence of IGF-1 (panel e, lanes 5 and 6), consistent with the
transient effect of aldosterone at this low concentration (see
Figure 3 and ref.20). The 1-h treatment with IGF-1 alone
(0.1 nM) induced no significant change of Sgk-1 protein pool
(panel c, lane 2), additive (lane 5) to the effect of aldoste-
rone alone (lane 4). The 1-h treatment with IGF-1 alone
(10 nM) induced a small change of Sgk-1 phoshorylation
Treatment + 300 nM aldo + 300 nM aldo + 300 pM IGF-1
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Figure 7 | Characterization of Sgk1 phosphorylation states and anti-Sgk antibody. mCCDcl1 cells were treated with 300 nM aldosterone for
2 h (a, first and second lanes), 300 nM aldosterone and 50mM LY294002 for 2 h (a, third and fourth lanes), or 0.3 nM IGF-1 for 1 h (b, two different
samples) before lysis; lysis buffer did not contain phosphatase inhibitors. Lysates were treated with l-phosphatase (NewEngland-BioLabs,
Ipswich, MA, USA) or only the phosphatase buffer, during 30 min at 301C, and reactions were stopped by adding SDS-PAGE sample buffer and
boiling at 951C for 5 min. Lysates were then analyzed by SDS-PAGE/Western blotting, using anti-Sgk (upper panels) and anti-actin (lower
panels) antibodies. A 25mg portion of total protein was analyzed in the first two lanes of the a, and 50mg in the third and fourth lanes of the a,
and on the b. A band that matches the calculated molecular weight of the non-phosphorylated Sgk1 (48.9 kDa) is indicated by an arrow head.
Three more slowly migrating bands, presumably different phosphorylation states of Sgk1, are indicated by a bracket. A nonspecific band is
indicated by a star.
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Figure 8 | A basolateral, but not an apical treatment with IGF-1,
induces an increase in Sgk1 expression and phosphorylation.
mCCDcl1 cells were treated with vehicle (lane 1), 10 nM IGF-1 on the
apical side (lane 2), 0.1 nM IGF-1 on the basolateral side (lane 3) or
10 nM IGF-1 on the basolateral side (lane 4) for 1 h before
electrophysiological measurements and lysis. Lysates were then
analyzed by SDS-PAGE/Western blotting using anti-Sgk and anti-actin
antibodies. (a) A representative blot of five independent experiments
is shown. Non-phosphorylated Sgk1 (48.9 kDa) is indicated by an
arrow head, and different putative phosphorylation states of Sgk1 by
a bracket. (b) Total Sgk1 expression levels were quantified and
normalized to actin expression levels (open bars); control condition
was considered 100% expression. (c) Blot and quantification results
are correlated with the treatment-induced current increase (delta of
the induced current as respect to t¼ 0 (Isc stimulatedIsc at t¼ 0)) at
the same time point as the Western blotting data.
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(panel a, lane 3) and Sgk1 protein pool (panel c, lane 3),
additive (lane 6) to the effect of aldosterone alone (lane 4).
The 6-h treatment with 300 nM aldosterone (Figure 10)
induced a massive increase in the non-phosphorylated Sgk1,
as well as in all phosphorylation states (panel a, lanes 4–6),
making relative quantification with respect to controls (lanes
1–3) not feasible. After maximal stimulation by aldosterone,
Sgk1 phosphorylation (panel a, lane 4 vs lane 5 or 6) and
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Figure 9 | Co-stimulation with 0.3 nM aldosterone and 0.3 nM IGF-1, either simultaneously or adding IGF-1 after a 5 h aldosterone
pretreatment, induces an additive effect on Sgk1 protein expression and phosphorylation. (a, c, e): mCCDcl1 cells were treated with IGF-1
vehicle (lanes 1 and 4), 0.1 nM IGF-1 (lanes 2 and 5) or 10 nM IGF-1 (lanes 3 and 6) for 1 h after a 5 h pretreatment with aldosterone vehicle (lanes
1–3) or 0.3 nM (lanes 4–6), before electrophysiological measurements and lysis. (b, d, f) mCCDcl1 cells were treated with vehicle (lane 1), 50mM
LY294002 (lane 2), 0.3 nM IGF-1 (lane 3), 0.3 nM aldosterone (lane 4), both IGF-1 and aldosterone (lane 5), IGF-1 and LY294002 (lane 6),
aldosterone and LY294002 (lane 7) or aldosterone, IGF-1 and LY294002 (lane 8) for 2 h before electrophysiological measurements and lysis. In
both experiments, lysates were then analyzed by SDS-PAGE/Western blotting, using anti-Sgk and anti-actin antibodies. A representative blot of
two independent experiments is shown (upper panels). Non-phosphorylated Sgk1 (48.9 kDa) is indicated by an arrow head, and different
putative phosphorylation states of Sgk1 by a bracket. Total Sgk1 expression levels were quantified and normalized to actin expression levels
(middle panels, open bars); control condition was considered 100% expression. Blot and quantification results are correlated with the
treatment-induced current increase (delta of the induced current as respect to t¼ 0 (Isc stimulatedIsc at t¼ 0)) at the same time point as the
Western blotting figures (lower panels).
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Figure 10 | Co-stimulation with 300 nM aldosterone and 0.3 nM IGF-1 simultaneously induces an additive effect on Sgk1 expression and
phosphorylation, but not when adding IGF-1 after a 5 h 300 nM aldosterone pretreatment. (a, c) mCCDcl1 cells were treated with IGF-1
vehicle (lanes 1 and 4), 0.1 nM IGF-1 (lanes 2 and 5) or 10 nM IGF-1 (lanes 3 and 6) for 1 h after a 5 h pretreatment with aldosterone vehicle (lanes
1–3) or 300 nM (lanes 4–6), before electrophysiological measurements and lysis. (b, d) mCCDcl1 cells were treated with 300 nM aldosterone (lane
1), both 0.3 nM IGF-1 and 300 nM aldosterone (lane 2), 300 nM aldosterone and 50 mM LY294002 (lane 3) or aldosterone, IGF-1, and LY294002 (lane
4) for 2 h before electrophysiological measurements and lysis. In both experiments, lysates were then analyzed by SDS-PAGE/Western blotting
using anti-Sgk and anti-actin antibodies. Non-phosphorylated Sgk1 (48.9 kDa) is signaled by an arrow head and different putative
phosphorylation states of Sgk1 by a bracket (upper panels). The figure shows a representative blot of two independent experiments correlated
with graph showing the treatment-induced current increase (delta of the induced current as respect to t¼ 0 (Isc stimulatedIsc at t¼ 0)) (lower
panels, closed bars) at the same time point as the Western blotting figures.
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sodium transport (panel c, lane 4 vs 5 or 6) appear to be
saturated and cannot be significantly increased by IGF-1.
Finally, we analyzed the role of the PI3-K on the IGF-1
induction of Sgk1 phosphorylation and sodium transport. As
the additive effect between 300 pM aldosterone and 300 pM
IGF-1 is highly significant after 2 h of stimulation (see Figure
6a), this time point was chosen for protein (Figure 9b and d)
and sodium transport analysis (Figure 9f). The non-
phosphorylated Sgk1 and three phosphorylation states are
visible in the control cells (panel b, lane 1). Addition of the
PI3-K inhibitor LY294002 decreased the high Mr phosphory-
lated Sgk1 species, the total protein pool (lane 2, panels b and
d), and baseline sodium transport (lane 2, panel f). Addition
of 300 pM IGF-1 increased the phosphorylation of Sgk-1 (lane
3, panel b) and its total pool (lane 3, panel d) and sodium
transport (lane 3, panel f). Addition of 300 pM aldosterone
induced a similar pattern (lane 4). A clear additive effect is
observed when both hormones were applied simultaneously
(lane 5, panels b, d, f). Addition of LY294002 completely
blocks the effect of IGF-1 (300 pM) and aldosterone
(300 pM), either applied separately or simultaneously, on
Sgk1 phosphorylation (lanes 6–8, panel b), Sgk1 protein pool
(lanes 6–8, panel d), or sodium transport (lanes 6–8, panel f).
Addition of LY294002 was also able to fully inhibit the effects
of 0.3 nM aldosterone and 300 pM IGF1 on the Sgk1
phosphorylation (Figure 10b, lanes 3 and 4), as well as
the sodium transport responses (panel d, lanes 3 and 4).
Overall, there was a striking correlation between the
biochemical and the physiological data (Figure 9e and d vs
f and Figure 10a, b vs c, d)
DISCUSSION
IGF-1 vs insulin: physiological relevance for sodium balance
In the present paper, we have examined the possible role of
insulin and IGF-1 in the same cellular model. To our surprise,
we observed that the cell line was highly responsive to IGF-1,
but not to insulin (Figure 2c). As the two dose–response
curves are parallel and reach the same maximal effect, the
responses are mediated by the same receptor. As the binding
properties of the IGF-1 and insulin receptors to their
respective ligand are similar (Table 1) with Kd at B0.8 to
1.0 nM, respectively, the observed insulin and IGF-1 responses
are mainly signaled through the IGF-1-R and not the Ins-R.
The cell line expresses both IGF-1-R Ins-R mRNA (data not
shown). Assuming that both proteins are expressed, the
insulin receptor would not mediate the sodium transport
responses, but could be involved in other growth and/or
metabolic responses. There is, however, good evidence that
insulin is an important factor in determining sodium balance
in vivo.5 Clearance studies demonstrate that insulin decreases
the fractional excretion of sodium. As the overall proximal
reabsorption of sodium was decreased, insulin was proposed
to act more distally. Along this line, evidence was provided
that insulin increased the loop segment sodium chloride
reabsorption in the euglycemic rat, pointing to a major effect
on sodium balance through its action in the thick ascending
limb. A further ex vivo study on perfused microdissected
CCD cells did not provide evidence for insulin action on
sodium transport in these segments.11 These in vivo and ex
vivo data are in contrast with in vitro observations in cultured
cell lines from amphibian and mammalian origins.6,7,9,27 In
these models, the insulin responsiveness was quite variable,
which may be related to species differences (amphibian vs
mammalian) or state of epithelial differentiation. In one
study,22 dose–response curves for insulin-stimulated Naþ
transport were performed in the A6, M1, and mpkCCDcl4 cell
lines. All three lines showed similar dose–response relation-
ships with K1/2 of 1–3 nM, a much higher affinity as reported
here (30–50 nM). The corresponding K1/2 for IGF-1 were
however not reported in this study, making a direct
comparison between the two hormones not possible. We
have no explanation for the differences in insulin K1/2
between the two studies. Clearly the A6 cells, M1 cells, and
mpk CCD cells do not recapitulate principal cell function as
well as the mCCD cells. The possibility that our culture
condition exposing the cells to high level of insulin could
explain a decreased responsiveness is unlikely, as the A6, M1,
and mpk CCD cells are also exposed to high insulin
concentration before the experiments. Moreover, we have
directly demonstrated that the K1/2 for insulin remained high
and constant (30–50 nM) even after depriving the cells from
insulin for 5 days. Growth hormone is secreted by the
pituitary in a pulsatile manner, leading to the production of
IGF-1. Remarkably, despite the pulsatile aspect of IGF-1
secretion, free plasma IGF-1 is not fluctuating during the
circadian cycle.19 At these concentrations, our data predict
that a significant fraction of basal sodium transport is
elicited. This is in contrast with the expected effect of
circulating insulin which is low on fasting (0.03–0.08 nM) and
reaches maximal values on feeding (B0.4 nM) (Table 1).
According to the present data, these concentrations would
not modify significantly the basal sodium transport. Our data
are consistent, therefore, with the concept of an insulin effect
on more proximal nephron segments, that is connecting
tabule (CNT), distal convoluted tubule (DCT), or thick
ascending limb. We are not suggesting, however, that insulin
does not mediate a biological effect in CCD, that is growth or
other metabolic/ionic effects distinct from the sodium
transport response. To confirm these hypotheses, the analysis
of ASDN-specific single and double knock-out for the IR and
the IGF-1R would be necessary, as such experimental
approach has already been demonstrated to be feasible, at
least in the pancreatic b cell.28
IGF-1 interactions with aldosterone: the PI3-kinase is a
limiting step in both signaling cascades
Little is known about the interaction of IGF-1 and
aldosterone in ASDN. In a mammalian cell line (MDCK),
the response to IGF-1 after 4 h of treatment with aldosterone
was statistically greater than the response to IGF-1 in non-
aldosterone-treated cultures.8 However, the concentra-
tions used (100 nM IGF-1 and 1 mM aldosterone) were largely
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supra-physiological. Physiological concentrations of aldoster-
one induce Naþ reabsorption, essentially by binding to the
mineralocorticoid receptor, while supra-physiological con-
centrations can also activate the glucocorticoid receptor
(GR).1,20 Here, we examined the interactions of aldosterone
and IGF-1 at physiological concentrations on sodium
transport (Figures 3a and 5) and Sgk1 phosphorylation and
protein pool (Figure 9). Only additive responses were
observed and these responses were fully inhibited by the
PI3-kinase inhibitor. These results suggest that both hor-
mones activate the same pathway at a point in the signaling
cascade downstream, but close to the receptor. Aldosterone
induces Sgk1 expression via the PI3-K pathway, as PI3-K
inhibitor blocks this induction (see above and23). As
suggested for the interaction between insulin and aldoster-
one,15 we propose that PI3-K regulation of Sgk1 would be the
crossover point between IGF-1 and aldosterone in the
stimulation of Naþ reabsorption. In conclusion, IGF-1-
dependent Naþ current may play a significant role. IGF-1
might be one of the hormones maintaining a basal level of
Sgk1 expression and, in turn, Nedd4-2 phosphorylation, in
the absence of aldosterone. IGF-1 could allow a rapid effect of
aldosterone on Naþ transport by maintaining continuously a
basal level of active PI3-K. Interestingly, aldosterone can
induce Sgk1 phosphorylation in the absence of IGF-1,
suggesting that aldosterone can also by itself activate the
PI3-K by a distinct and unknown pathway.
MATERIALS AND METHODS
Electrophysiological measurements
The mCCDcl1 cell line was obtained by spontaneous transformation
of primary cultures of CCD microdissected from mouse kidneys and
electrophysiological measurements were performed, as described
previously.20 Unless indicated, aldosterone was applied on both sides
of the cells, and insulin and IGF-1 only on the basolateral side. All
the experiments were done on cells of passage 23 to 31. Each
experiment was repeated three times on cells from at least two
different passages; in each experiment, there were three filters per
passage per condition. Short circuit current (Isc in mA/cm
2),
potential difference (PD in mV), and electrical resistance
(Ohms cm2) were recorded in a modified Ussing chamber under
sterile conditions.
Culture media (Dulbecco’s modified Eagle’s medium (DMEM/
Ham’s F12 1:1 vol/vol)) were from Gibco Invitrogen (Carlsbad, CA,
USA). Hormones and reagents were from Sigma (St Louis, MO,
USA). Fetal calf serum from Fisher Scientific (Wohlen, Switzerland)
and rat tail collagen were selected, as described previously.20 Tissue
culture-treated Transwell (0.4 mM pore size, 4.5 cm2 diameter) were
from Corning Costar Corp. (Cambridge, MA, USA).
Kinetic parameters (K1/2: half-activation constant, and Iscmax:
maximal Isc) for one site model were calculated, using a nonlinear
fit routine.
Western blotting
mCCDcl1 cells grown on filters were lysed after the correspond-
ing electrophysiological measurements in lysis buffer (50 mM
HEPES (pH 7.5), 150 mM NaCl, 1.5 mM MgCl2, 1 mM EGTA, 10%
glycerol, and 1% Triton X-100) that contained protease inhibitors
(1 mM PMSF, 10 mg/ml leupeptin, 10mg/ml pepstatin A, and
10 mg/ml aprotinin) and phosphatase inhibitors (100 mM NaF,
10 mM Na-pyrophosphate, and 10 mM Na-orthovanadate), except
when indicated. The lysate was centrifuged (20 000 g, 41C, 15 min)
and the supernatant was recovered. Samples were quantified by the
Bradford method (Coo protein Assay Reagent, Brunschwig, Switzer-
land) and 50 mg of total protein were charged on 10% SDS-PAGE
gels, except when indicated. After transfer on nitrocellulose, they
were analyzed by Western blotting with Sgk and actin antibodies
(Sigma), as recommended by the manufacturer. Quantification of
protein expression levels was performed on the fluorograms, using a
molecular imager FX (Biorad, Hercules, CA, USA). Owing to the
close position of the phosphorylated and non-phosphorylated Sgk1
bands in the immunoblots, only quantification of total Sgk1 was
possible; changes in the quantified values obtained can in consequence
be due to an increase in the expression or in the phosphorylation of
Sgk1. Sgk1 expression levels were normalized to actin. The results are
expressed as a percentage of the vehicle-treated cells (100%).
Statistical analysis
Results are given as means7s.e.m. for n experiments. Statistical
differences between groups were calculated, using the unpaired two-
tailed t-test.
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